Dilaforette is a Swedish drug development company developing sevuparin, an innovative, proprietary polysaccharide drug, which has potential to restore blood flo...
| Website | http://www.dilaforette.se |
| Revenue | $200000 |
| Employees | View employees |
| Address | Fogdevreten 2A, Solna, Stockholm 171 65, SE |
| Technologies |
JavaScript
,
HTML
,
reCAPTCHA
+12 more
(view full list)
|
| Industry | Pharmaceuticals, Healthcare, Biotechnology, Drug Manufacturing & Research |
| Competitors | Roche, Pfizer, Amgen, AstraZeneca, Novartis, Sanofi, Ferring Pharmaceuticals, Sobi - Swedish Orphan Biovitrum AB (publ), Bavarian Nordic, Takeda +37 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 2834 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular Dilaforette AB employee's phone or email?
The Dilaforette AB annual revenue was $200000 in 2026.
Dilaforette AB is based in Solna, Stockholm.
The NAICS codes for Dilaforette AB are [32541, 325, 32, 3254].
The SIC codes for Dilaforette AB are [283, 2834, 28].